To learn more about the Value-driven Engineering initiative and those supporting it, browse the topics below:

What is Value-driven Engineering

With the aim of retaining America’s lead in medical device development and innovation, the Austen BioInnovation Institute in Akron (ABIA) has gathered leaders from industry, academia and the public and private sectors for the “Value-driven Engineering and U.S. Global Competitiveness” national initiative. Led by Dr. Frank L. Douglas, ABIA President and CEO, the effort is geared at providing researchers, device manufacturers and federal legislators with a pathway for industry action and public policy steps necessary to advance America’s capabilities in the face of rising competition from global forces.

As healthcare costs are inextricably linked to the health of the nation’s economy, the initiative’s success will valuably enhance U.S. competitiveness on the global stage, save and create jobs and fuel innovation. The ultimate goal is to improve quality of care while reducing the cost of care, thereby adding value to the patient and the payer. Learn more…

What is the Austen BioInnovation Institute in Akron

The Austen BioInnovation Institute in Akron (ABIA) is a unique collaboration of complementary research, education and health institutions that expands Akron’s rich legacy in materials science to pioneer the next generation of life-enhancing and life-saving biomedical innovation for the 21st Century. It is dedicated to becoming a global leader in biomaterial and medical research, education, clinical services and commercialization; and a driver of transformative economic, social and health benefits for Greater Akron. Learn more…

Who is leading the effort

A steering committee led by Frank Douglas, PhD, MD, President and CEO of the Austen BioInnovation Institute in Akron (ABIA), heads the Value-driven Engineering and U.S. Global Competitiveness movement, which includes the following leaders:

Soumyadipta Acharya, MD, MSE, PhD
Assistant Professor, Biomedical Engineering, Johns Hopkins University

Brian L. Davis, PhD
Vice President, Medical Device Development Center, Austen BioInnovation Institute in Akron

Ali Dhinojwala, PhD
Department Chair, H.A. Morton Professor in Polymer Science, The University of Akron

Frank L. Douglas, PhD, MD (Chair)
President and CEO, Austen BioInnovation Institute in Akron

Stephen Fening, PhD
Director of Orthopaedic Devices, Medical Device Development Center, Austen BioInnovation Institute in Akron

Martha Gray, PhD
J.W. Kieckhefer Professor of Medical and Electrical Engineering, Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology

A. Seth Greenwald, DPhil (Oxon)
Director, Orthopaedic Research Laboratories

Jonathan F.I. Greenwald
Business Development Director, Orthopaedic Research Laboratories

William J. Heetderks, PhD, MD
Director, Extramural Science Program, National Institute of Biomedical Imaging and Bioengineering

Mike Hess
Vice President, Innovation Excellence, Medtronic Inc.

A. Jay Khanna, MD, MBA
Associate Professor of Orthopaedic Surgery and Biomedical Engineering, Johns Hopkins University

Uday N. Kumar, MD
Founder and Chief Medical Officer, iRhythm Technologies Inc. and Fellowship Director, Biodesign Program, Stanford University

Youseph Yazdi, PhD, MBA
Executive Director, Center for Bioengineering Innovation and Design, Johns Hopkins University